Comparing Recent Guidelines on the Conduct of Clinical Trials: ICH, FDA, and WHO
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-D-019-Monday
- By: ROOHI, Elnaz (Islamic Azad University, Pharmaceutical Sciences Branch, Faculty of Pharmacy., Tehran, Iran, Islamic Republic Of)
- Co-author(s): Elnaz Roohi: Department of Clinical Pharmacy, Faculty of Pharmacy, Islamic Azad University, Pharmaceutical Sciences Branch., Tehran, Iran, Islamic Republic Of
Farshad Hashemian: Department of Clinical Pharmacy, Faculty of Pharmacy, Islamic Azad University, Pharmaceutical Sciences Branch., Tehran, Iran, Islamic Republic Of - Abstract:
Backgrounds
During the past years, regulatory authorities have published guidelines on the conduct of clinical trials.Aims
The aim of the present article was to study and compare regulatory requirements and procedure for conducting clinical trials in order to provide further insight for clinical investigators, pharmaceutical manufacturers,.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023